Information only, not medical advice. Talk to your doctor or pharmacist.
Full list
175 approvals (204 source records) dated January 1, 2025 through . Data pulled .
Health Canada
UnclassifiedAFICAMTEN 5 MG; AFICAMTEN 10 MG; AFICAMTEN 15 MG; AFICAMTEN 20 MG
This DPD record had no therapeutic class in the pull, so the condition is Unclassified.
Health Canada
UnclassifiedNERANDOMILAST 9 MG; NERANDOMILAST 18 MG
Therapeutic class L04AA61 NERANDOMILAST did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedREMIBRUTINIB 25 MG
Therapeutic class L04AA60 REMIBRUTINIB did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedTRENIBOTULINUMTOXINE 1400 UNIT
Therapeutic class M03AX01 BOTULINUM TOXIN did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedDENECIMIG 1.6 MG; DENECIMIG 4 MG; DENECIMIG 9 MG; DENECIMIG 20 MG; DENECIMIG 46 MG
Therapeutic class B02BX OTHER SYSTEMIC HEMOSTATICS did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedDONIDALORSEN (DONIDALORSEN SODIUM) 80 MG
Therapeutic class B06AC09 DONIDALORSEN did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedTIRATRICOL 350MCG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZILURGISERTIB FUMARATE EQ 25MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedTAVAPADON 15MG; TAVAPADON 5MG; TAVAPADON 10MG; TAVAPADON 0.25MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyZONGERTINIB 60 MG
Condition mapped from Health Canada ATC L01EH04 ZONGERTINIB.
FDA
UnclassifiedLIRAFUGRATINIB HYDROCHLORIDE EQ 20MG BASE; LIRAFUGRATINIB HYDROCHLORIDE EQ 30MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedINSULIN EFSITORA ALFA-GOBE 1000 UNITS/ML; INSULIN EFSITORA ALFA-GOBE 500 UNITS/ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedROPEGINTERFERON ALFA-2B 500 MCG
Therapeutic class L03AB15 ROPEGINTERFERON ALFA-2B did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedAPITEGROMAB-MSTN 150MG/3ML (50MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedFLORETYROSINE F-18 5-300mCi/ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
MalariaARTESUNATE 110 MG
Condition mapped from Health Canada ATC P01B ANTIMALARIALS.
FDA
UnclassifiedCAMIZESTRANT 75MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZILGANERSEN SODIUM EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedRUSFERTIDE ACETATE EQ 54MG BASE/VIAL; RUSFERTIDE ACETATE EQ 28MG BASE/VIAL; RUSFERTIDE ACETATE EQ 9.5MG BASE/VIAL; RUSFERTIDE ACETATE EQ 41MG BASE/VIAL; RUSFERTIDE ACETATE EQ 19MG BASE/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedBREPOCITINIB TOSYLATE EQ 30MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedDARAXONRASIB 100MG; DARAXONRASIB 150MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedGARETOSMAB-GRTS 300MG/5ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedFLORQUINITAU F-18 1-40mCi/ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedIBERDOMIDE HYDROCHLORIDE EQ 1MG BASE; IBERDOMIDE HYDROCHLORIDE EQ 0.75MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyPIMICOTINIB (PIMICOTINIB HYDROCHLORIDE) 25 MG
Condition mapped from Health Canada ATC L01X OTHER ANTINEOPLASTIC AGENTS.
FDA
UnclassifiedOVEPOREXTON 2MG; OVEPOREXTON .05MG; OVEPOREXTON 1MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedCAMIZESTRANT 75 MG
Therapeutic class L02BA05 CAMIZESTRANT did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedGADOQUATRANE 257.9 MG
Therapeutic class V08CA13 GADOQUATRANE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedCENTANAFADINE HYDROCHLORIDE 280MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZIDESAMTINIB 25MG; ZIDESAMTINIB 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedGADOPICLENOL 485.1 MG
Therapeutic class V08CA12 GADOPICLENOL did not match one condition rule, so the condition is Unclassified.
Health Canada
Obstructive airway diseaseDEPEMOKIMAB 100 MG
Condition mapped from Health Canada ATC R03DX12 DEPEMOKIMAB.
Health Canada
Unclassified*RSV F-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA 50 MCG
Therapeutic class J07BX05 RESPIRATORY SYNCYTIAL VIRUS VACCINE did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedMELATONIN 1 MG; MELATONIN 5 MG
Therapeutic class N05CH01 MELATONIN did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedENLICITIDE DECANOATE EQ 20MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedELINZANETANT 60 MG
Therapeutic class G02CX07 ELINZANETANT did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedGEDATOLISIB 180MG/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyTOVORAFENIB 100 MG; TOVORAFENIB 25 MG
Condition mapped from Health Canada ATC L01EC04 TOVORAFENIB.
Health Canada
UnclassifiedAFAMELANOTIDE (AFAMELANOTIDE ACETATE) 16 MG
Therapeutic class D02BB02 AFAMELANOTIDE did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedLENIOLISIB (LENIOLISIB PHOSPHATE) 70 MG
Therapeutic class L03AX22 LENIOLISIB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedATACICEPT-VYMJ 150MG/ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedDONANEMAB 17.5 MG
Therapeutic class N06DX05 DONANEMAB did not match one condition rule, so the condition is Unclassified.
Health Canada
CardiovascularPLOZASIRAN (PLOZASIRAN SODIUM) 25 MG
Condition mapped from Health Canada ATC C10AX OTHER LIPID MODIFYING AGENTS.
Health Canada
CardiovascularATRASENTAN (ATRASENTAN HYDROCHLORIDE) 0.75 MG
Condition mapped from Health Canada ATC C09XX OTHER AGENTS ACTING ON THE RENIN -ANGIOTENSIN SYSTEM.
FDA
UnclassifiedVELIGROTUG-VVZE 500MG/10ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedCHIKUNGUNYA VIRUS VIRUS-LIKE PARTICLE 40 MCG
Therapeutic class J07BP02 CHIKUNGUNYA, VIRUS-LIKE PARTICLES did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedTEBIPENEM PIVOXIL HYDROBROMIDE EQ 300MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedGADOQUATRANE 7.737GM/30ML (257.9MG/ML); GADOQUATRANE 2.579GM/10ML (257.9MG/ML); GADOQUATRANE 0.5158GM/2ML (257.9MG/ML); GADOQUATRANE 16.7635GM/65ML (257.9MG/ML); GADOQUATRANE 3.8685GM/15ML (257.9MG/ML); GADOQUATRANE 1.93425GM/7.5ML (257.9MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedCIPEPOFOL 50MG/20ML (2.5MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedPEGZILARGINASE 5 MG
Therapeutic class A16AB24 PEGZILARGINASE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedENSITRELVIR 125MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedPIVEKIMAB SUNIRINE-PVZY 2MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedBULEVIRTIDE-GMOD 8.5MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedBAXDROSTAT 1MG; BAXDROSTAT 2MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedSONROTOCLAX 20MG; SONROTOCLAX 1MG; SONROTOCLAX 80MG; SONROTOCLAX 5MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedETRANACOGENE DEZAPARVOVEC 10000000000000 GENOME COPIES
Therapeutic class B02BD16 ETRANACOGENE DEZAPARVOVEC did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedPEGUNIGALSIDASE ALFA 5 MG; PEGUNIGALSIDASE ALFA 20 MG
Therapeutic class A16AB20 PEGUNIGALSIDASE ALFA did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologyMOSUNETUZUMAB 1 MG
Condition mapped from Health Canada ATC L01FX25 MOSUNETUZUMAB.
Health Canada
UnclassifiedVOSORITIDE 0.4 MG; VOSORITIDE 0.56 MG; VOSORITIDE 1.2 MG
Therapeutic class M05BX07 VOSORITIDE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedVEPDEGESTRANT 200MG; VEPDEGESTRANT 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedVAMOROLONE 40 MG
Therapeutic class H02AB18 VAMOROLONE did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologySEVABERTINIB 10 MG
Condition mapped from Health Canada ATC L01EH06 SEVABERTINIB.
FDA
UnclassifiedORFORGLIPRON CALCIUM EQ 2.5MG BASE; ORFORGLIPRON CALCIUM EQ 14.5MG BASE; ORFORGLIPRON CALCIUM EQ 5.5MG BASE; ORFORGLIPRON CALCIUM EQ 0.8MG BASE; ORFORGLIPRON CALCIUM EQ 17.2MG BASE; ORFORGLIPRON CALCIUM EQ 9MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyTISLELIZUMAB 100 MG
Condition mapped from Health Canada ATC L01FF09 TISLELIZUMAB.
FDA
UnclassifiedINSULIN ICODEC
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedRELACORILANT 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedTIVIDENOFUSP ALFA-EKNM 150MG/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedICOTROKINRA HYDROCHLORIDE EQ 200MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedLINERIXIBAT 40MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyNADOFARAGENE FIRADENOVEC 300000000000 VP
Condition mapped from Health Canada ATC L01XL10 NADOFARAGENE FIRADENOVEC.
Health Canada
UnclassifiedCYSTEAMINE HYDROCHLORIDE 0.44 % W/V
Therapeutic class S01XA21 MERCAPTAMINE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedNAVEPEGRITIDE 2.8MG/VIAL; NAVEPEGRITIDE 5.5MG/VIAL; NAVEPEGRITIDE 1.3MG/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedNEMOLIZUMAB 30 MG
Therapeutic class D11AH12 NEMOLIZUMAB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedPEGZILARGINASE-NBLN 0.1MG/KG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedMILSAPERIDONE 4MG; MILSAPERIDONE 1MG; MILSAPERIDONE 10MG; MILSAPERIDONE 6MG; MILSAPERIDONE 2MG; MILSAPERIDONE 12MG; MILSAPERIDONE 8MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedDIFAMILAST 1%
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedRIFAPENTINE 150 MG
Therapeutic class J04AB05 RIFAPENTINE did not match one condition rule, so the condition is Unclassified.
Health Canada
CardiovascularBEMPEDOIC ACID 180 MG
Condition mapped from Health Canada ATC C10AX15 BEMPEDOIC ACID.
Health Canada
CardiovascularOLEZARSEN (OLEZARSEN SODIUM) 80 MG
Condition mapped from Health Canada ATC C10AX OTHER LIPID MODIFYING AGENTS.
Health Canada
UnclassifiedDELAFLOXACIN (DELAFLOXACIN MEGLUMINE) 450 MG; DELAFLOXACIN (DELAFLOXACIN MEGLUMINE) 300 MG
Therapeutic class J01MA23 DELAFLOXACIN did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedCLESROVIMAB 105 MG
Therapeutic class J06BD10 CLESROVIMAB did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedPALOPEGTERIPARATIDE 168 MCG
Therapeutic class H05AA05 PALOPEGTERIPARATIDE did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologyTORIPALIMAB 40 MG
Condition mapped from Health Canada ATC L01FF13 TORIPALIMAB.
Health Canada
UnclassifiedNIPOCALIMAB 300 MG; NIPOCALIMAB 1200 MG
Therapeutic class L04AL03 NIPOCALIMAB did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedTEPROTUMUMAB 500 MG
Therapeutic class L04AG13 TEPROTUMUMAB did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologyZANIDATAMAB 300 MG
Condition mapped from Health Canada ATC L01FD07 ZANIDATAMAB.
FDA
UnclassifiedCOPPER HISTIDINATE 2.9MG/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyMIRVETUXIMAB SORAVTANSINE 100 MG
Condition mapped from Health Canada ATC L01FX26 MIRVETUXIMAB SORAVTANSINE.
FDA
UnclassifiedTRADIPITANT 85MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
CardiovascularAPROCITENTAN 25 MG
Condition mapped from Health Canada ATC C02KN01 APROCITENTAN.
FDA
UnclassifiedNARSOPLIMAB-WUUG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedAFICAMTEN 20MG; AFICAMTEN 10MG; AFICAMTEN 15MG; AFICAMTEN 5MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedOSILODROSTAT (OSILODROSTAT PHOSPHATE) 1 MG; OSILODROSTAT (OSILODROSTAT PHOSPHATE) 5 MG
Therapeutic class H02CA02 OSILODROSTAT did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedDEPEMOKIMAB-ULAA 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedLECANEMAB 100 MG
Therapeutic class N06DX04 LECANEMAB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedETRIPAMIL 70MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedLERODALCIBEP-LIGA 300MG/1.2ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZOLIFLODACIN 3GM/PACKET
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedCIPAGLUCOSIDASE ALFA 105 MG
Therapeutic class A16AB23 CIPAGLUCOSIDASE ALFA did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedZURANOLONE 30 MG
Therapeutic class N06AX31 ZURANOLONE did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedSEPIAPTERIN 250 MG; SEPIAPTERIN 1000 MG
Therapeutic class A16AX28 SEPIAPTERIN did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologyPIRTOBRUTINIB 50 MG; PIRTOBRUTINIB 100 MG
Condition mapped from Health Canada ATC L01EL05 PIRTOBRUTINIB.
Health Canada
UnclassifiedSELADELPAR (SELADELPAR LYSINE) 10 MG
Therapeutic class A05AX07 SELADELPAR did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedSIBEPRENLIMAB-SZSI 400MG/2ML(200MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedSEVABERTINIB 10MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedPLOZASIRAN SODIUM EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZIFTOMENIB 200MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedCROVALIMAB 170 MG
Therapeutic class L04AJ07 CROVALIMAB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedDOXECITINE 2GM/PACKET; DOXRIBTIMINE 2GM/PACKET
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyQUIZARTINIB (QUIZARTINIB HYDROCHLORIDE) 17.7 MG
Condition mapped from Health Canada ATC L01EX11 QUIZARTINIB.
FDA
UnclassifiedELINZANETANT 60MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
Viral infectionsBULEVIRTIDE (BULEVIRTIDE ACETATE) 2 MG
Condition mapped from Health Canada ATC J05AX28 BULEVIRTIDE.
FDA
UnclassifiedNERANDOMILAST 18MG; NERANDOMILAST 9MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedREMIBRUTINIB 25MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
Unclassified*SARSCOV2 S-PROTEIN NTD-RBD SUBDOMAINS MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA 10 MCG
Therapeutic class J07BN01 COVID-19, RNA-BASED VACCINE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedIMLUNESTRANT TOSYLATE EQ 200MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedTAPINAROF 1 %
Therapeutic class D05AX07 TAPINAROF did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedPALTUSOTINE HYDROCHLORIDE EQ 20MG BASE; PALTUSOTINE HYDROCHLORIDE EQ 30MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedELAMIPRETIDE HYDROCHLORIDE EQ 280MG BASE/3.5ML (EQ 80MG BASE/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedPEMBROLIZUMAB 790MG/9600UNITS(4.8ML); BERAHYALURONIDASE ALFA-PMPH; PEMBROLIZUMAB 395MG/4800UNITS(2.4ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedORITAVANCIN (ORITAVANCIN PHOSPHATE) 400 MG; ORITAVANCIN (ORITAVANCIN PHOSPHATE) 1200 MG
Therapeutic class J01XA05 ORITAVANCIN did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedROZANOLIXIZUMAB 280 MG
Therapeutic class L04AL02 ROZANOLIXIZUMAB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedRILZABRUTINIB 400MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedDELGOCITINIB 20 MG
Therapeutic class D11AH11 DELGOCITINIB did not match one condition rule, so the condition is Unclassified.
Health Canada
CardiovascularAMLODIPINE BESYLATE 5 MG; AMLODIPINE BESYLATE 10 MG
Condition mapped from Health Canada ATC C08CA01 AMLODIPINE.
FDA
UnclassifiedDONIDALORSEN SODIUM EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
DiabetesTEPLIZUMAB 2 MG
Condition mapped from Health Canada ATC A10XX01 TEPLIZUMAB.
Health Canada
OncologyLIFILEUCEL 72000000000 CELLS
Condition mapped from Health Canada ATC L01XL11 LIFILEUCEL.
Health Canada
OncologyRETIFANLIMAB 25 MG
Condition mapped from Health Canada ATC L01FF10 RETIFANLIMAB.
FDA
UnclassifiedBRENSOCATIB 25MG; BRENSOCATIB 10MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyBELANTAMAB MAFODOTIN 70 MG; BELANTAMAB MAFODOTIN 100 MG
Condition mapped from Health Canada ATC L01FX15 BELANTAMAB MAFODOTIN.
FDA
UnclassifiedZONGERTINIB 60MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedGARADACIMAB 200 MG
Therapeutic class B06AC07 GARADACIMAB did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedDORDAVIPRONE HYDROCHLORIDE EQ 125MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedACECLIDINE HYDROCHLORIDE EQ 1.44% BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedAMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 2.5 MG
Therapeutic class N06BA01 AMFETAMINE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedSEPIAPTERIN 1GM/PACKET; SEPIAPTERIN 250MG/PACKET
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedDELGOCITINIB 2%
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedSEBETRALSTAT 300MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedLINVOSELTAMAB-GCPT 5MG/2ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedSUNVOZERTINIB 200MG; SUNVOZERTINIB 150MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedDATOPOTAMAB DERUXTECAN-DLNK 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedGARADACIMAB-GXII 200MG/1.2ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedTALETRECTINIB ADIPATE EQ 200MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedFECAL MICROBIOTA 50000000000 CFU
Therapeutic class A07FA ANTIDIARRHEAL MICROORGANISMS did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedCLESROVIMAB-CFOR 105MG/0.7ML
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedOMAVELOXOLONE 50 MG
Therapeutic class N07XX OTHER NERVOUS SYSTEM DRUGS did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedACOLTREMON 0.003%
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedELAFIBRANOR 80 MG
Therapeutic class A05AX06 ELAFIBRANOR did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedTELISOTUZUMAB VEDOTIN-TLLV 20MG; TELISOTUZUMAB VEDOTIN-TLLV 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedTOFERSEN 100 MG
Therapeutic class N07XX22 TOFERSEN did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedAVUTOMETINIB POTASSIUM EQ 0.8MG BASE; DEFACTINIB HYDROCHLORIDE EQ 200MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedNIPOCALIMAB-AAHU 1200MG/6.5ML(185MG/ML); NIPOCALIMAB-AAHU 300MG/1.62ML(185MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyLAZERTINIB (LAZERTINIB MESYLATE) 80 MG; LAZERTINIB (LAZERTINIB MESYLATE) 240 MG
Condition mapped from Health Canada ATC L01EB09 LAZERTINIB.
FDA
UnclassifiedPENPULIMAB-KCQX 100MG/10ML(10MG/ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyINAVOLISIB 3 MG; INAVOLISIB 9 MG
Condition mapped from Health Canada ATC L01EM06 INAVOLISIB.
FDA
UnclassifiedATRASENTAN HYDROCHLORIDE EQ 0.75MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyZOLBETUXIMAB 100 MG
Condition mapped from Health Canada ATC L01FX31 ZOLBETUXIMAB.
Health Canada
UnclassifiedIPTACOPAN (IPTACOPAN HYDROCHLORIDE) 200 MG
Therapeutic class L04AJ08 IPTACOPAN did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedFITUSIRAN SODIUM EQ 20MG BASE/0.2ML (EQ 20MG BASE/0.2ML); FITUSIRAN SODIUM EQ 50MG BASE/0.5ML (EQ 50MG BASE/0.5ML)
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
Unclassified*ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 250 UNIT
Therapeutic class B02BD02 COAGULATION FACTOR VIII did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedGEPOTIDACIN MESYLATE EQ 750MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedSIPAVIBART 150 MG
Therapeutic class J06BD09 SIPAVIBART did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedZILUCOPLAN (ZILUCOPLAN SODIUM) 16.6 MG; ZILUCOPLAN (ZILUCOPLAN SODIUM) 23 MG; ZILUCOPLAN (ZILUCOPLAN SODIUM) 32.4 MG
Therapeutic class L04AJ06 ZILUCOPLAN did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedFEZOLINETANT 45 MG
Therapeutic class G02CX06 FEZOLINETANT did not match one condition rule, so the condition is Unclassified.
Health Canada
OncologyLONCASTUXIMAB TESIRINE 10 MG
Condition mapped from Health Canada ATC L01FX22 LONCASTUXIMAB TESIRINE.
Health Canada
Viral infectionsBALOXAVIR MARBOXIL 80 MG
Condition mapped from Health Canada ATC J05AX25 BALOXAVIR MARBOXIL.
Health Canada
OncologyTALQUETAMAB 2 MG; TALQUETAMAB 40 MG
Condition mapped from Health Canada ATC L01FX29 TALQUETAMAB.
FDA
UnclassifiedVIMSELTINIB 20MG; VIMSELTINIB 30MG; VIMSELTINIB 14MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
UnclassifiedTROFINETIDE 200 MG
Therapeutic class N07XX24 TROFINETIDE did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedMIRDAMETINIB 3MG; MIRDAMETINIB 4MG; MIRDAMETINIB 1MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedSUZETRIGINE 50MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedTREOSULFAN 1GM/VIAL; TREOSULFAN 5GM/VIAL
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
Health Canada
OncologyMOMELOTINIB (MOMELOTINIB DIHYDROCHLORIDE) 100 MG; MOMELOTINIB (MOMELOTINIB DIHYDROCHLORIDE) 150 MG; MOMELOTINIB (MOMELOTINIB DIHYDROCHLORIDE) 200 MG
Condition mapped from Health Canada ATC L01EJ04 MOMELOTINIB.
FDA
UnclassifiedDATOPOTAMAB DERUXTECAN-DLNK 100MG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.